Table 2.
Therapy termination rates at 1 year
| Risk of therapy termination, n (%) | Reduction in risk of therapy termination for proactive vs. standard management (%) | p-value | ||
|---|---|---|---|---|
| Standard management | Proactive strategy | |||
| Overall | 373/3401 (11.0) | 185/3401 (5.4) | 50.4 | <0.001 |
| Male | 262/2543 (10.3) | 130/2527 (5.1) | 50.1 | <0.001 |
| Female | 111/858 (12.9) | 55/874 (6.3) | 51.4 | <0.001 |
| APAP/CPAP | 350/3117 (11.2) | 177/3127 (5.7) | 49.6 | <0.001 |
| ASV/Bilevel | 23/284 (8.1) | 8/274 (2.9) | 63.9 | 0.011 |
| Public | 335/2902 (11.5) | 163/2904 (5.6) | 51.3 | <0.001 |
| Private | 38/499 (7.6) | 22/497 (4.4) | 42.1 | 0.034 |
APAP automatic continuous positive airway pressure, ASV adaptive servo-ventilation, Bilevel bilevel positive airway pressure, CPAP continuous positive airway pressure